How to Open a Sober Living Home: An Operator’s Guide to Certification, Zoning, and Federal Enforcement Risk

This is where founders get themselves indicted. EKRA, codified at 18 U.S.C. § 220, criminalizes paying or receiving remuneration in exchange for referrals to a recovery home, clinical treatment facility, or laboratory. EKRA applies to services covered by any “health care benefit program,” not just federal health care programs (e.g., Medicare, Medicaid, and TRICARE). Thus, EKRA enables the federal government to investigate and prosecute payment arrangements involving services reimbursed by any health plan. Violation of EKRA is a felony punishable by a maximum fine of $200,000, prison for up to 10 years, or both, for each occurrence. The HHS Office of Inspector General (OIG) coordinates on parallel Anti-Kickback Statute exposure, so operators should assume a single referral scheme can generate multiple enforcement tracks.

The commission-based marketer question is the single most common EKRA trap for new sober living operators. The EKRA employee safe-harbor only applies to payments that do not vary with the volume of referrals. Thus, under EKRA, covered entities may not pay their employees on a commission basis. If your business development rep gets a bonus per admission, you have an EKRA problem. In June 2025, the Ninth Circuit in United States v. Schena expanded liability further. The court concluded that marketing intermediaries who interact with ordering providers can fall under EKRA, further clarifying that payments do not have to go directly to the provider to violate EKRA.

Now to Arizona. Between 2019 and 2023, unlicensed sober living operators exploited fee-for-service billing gaps in the American Indian Health Program. New behavioral health fraud investigations had dropped from about 1,400 at the scandal’s peak in 2023 to 270 as of August 2025, according to AHCCCS. The figures include both civil and criminal cases, with some providers facing multiple investigations. By comparison, just nine cases were opened statewide in 2019, before the scheme came to light. The state has so far indicted more than 100 individuals and recouped $125 million. AHCCCS Director Carmen Heredia has been direct about the agency’s posture: “our priority remains on health equity, access to care, quality care and the elimination of fraud in our program.” Every operator opening a new home in 2026 should assume that state Medicaid agencies, commercial payer SIUs, and the DOJ are calibrated to that same standard.

Why does this matter for outcomes and for underwriting? Because the research supporting recovery housing is real, and it is what justifies your existence to a skeptical regulator. Studies from Leonard Jason’s team at DePaul have consistently shown that compared with men and women who went to aftercare as usual, individuals in Oxford Houses had less SUD relapse, higher employment, less poverty, and lower rates of incarceration. Those who stayed six months in Oxford House demonstrated lower substance use relapse, criminal justice recidivism, and aggressive behavior at one-year follow-up compared to those who stayed less than six months. These studies suggest that residency in an Oxford House for at least six months may be a critical factor in maintaining abstinence. Six months. That should shape your length-of-stay assumptions in the pro forma, and it should shape how you talk to referring IOP and PHP partners.